Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Not stated	2025-10-02		NCT04495556

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cedars-Sinai Medical Center	161
National Institute of Neurological Disorders and Stroke (NINDS)	370
National Institutes of Health (NIH)	667
The Cleveland Clinic	239
University of Pennsylvania	502

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cedars-Sinai Medical Center	Los Angeles	United States	392
Cleveland Clinic Foundation	Cleveland	United States	370
Johns Hopkins University	Baltimore	United States	49
St. Michael's Hospital of Unity Health Toronto	Toronto	Canada	1
The University of Texas at Austin	Austin	United States	1
University of Colorado	Aurora	United States	147
University of Pennsylvania	Philadelphia	United States	507
University of Southern California	Los Angeles	United States	25
University of Vermont	Burlington	United States	9
Washington University in St. Louis	St Louis	United States	35
Yale University	New Haven	United States	352